{"name":"MedRegen LLC","slug":"medregen-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MRG-001","genericName":"MRG-001","slug":"mrg-001","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"MRG-001","genericName":"MRG-001","slug":"mrg-001","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOM1p2Rlo5VnFLU3RPd1FQUFpSQy0xOUFtN2NyMnRWVGdnbUwxNklRaHJPSTQxM3FiSXpydG1zTEVzQnh6djREU3JlSEI3ZUFDV0VYSlU2M3ZrazRkNVFfSTd2TXNtekN5U0RRSURxbFFDXzlsLW5TNEJvMXZaWE9sZnpMR0FiZXMzcmhZMFlLejJPbnZXTzVzNmNGSlQ3eFZzd0ZpY29vM0ZVZV9mN1VxRjNnWE1DNnlIUHhTQkZ3UzQ?oc=5","date":"2022-08-02","type":"pipeline","source":"Fierce Pharma","summary":"Regeneron puts kibosh on 4 antibody studies as Pfizer's Paxlovid dominates the COVID treatment scene - Fierce Pharma","headline":"Regeneron puts kibosh on 4 antibody studies as Pfizer's Paxlovid dominates the COVID treatment scene","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}